Ok so here is the deal.
I understand many pharma companies are trying to cash in on treatment for COVID-19.
Mesoblast, has a massive head start on competitors in treating disease with Mesenchymal Stem Cells.
When I say head start, I mean they have at least 5-10 years on most competitors and heavily scrutinized clinical trial data on their remestemcel-L/temcell product.
They are a global leader and so when Professor Silviu Itescu says they are in active discussions with Governments for use of remestemcel-L an advanced and commercial product then I think it’s time the market sat up and finally listened.
This isn’t a cure however studies show the product has the potential and described in the announcment to treat this life- threatening virus and stabilise high-risk patients to a pathway of full recovery.
This is for real and yes the announcement should have come a little earlier as I suggested a few days ago.
But it’s here and Mesoblast is in a great position to help the globe.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-29
-
- There are more pages in this discussion • 415 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 0.945 |
6 | 52140 | 0.940 |
8 | 92185 | 0.935 |
5 | 73150 | 0.930 |
4 | 51132 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 20225 | 5 |
0.955 | 42472 | 3 |
0.960 | 80775 | 4 |
0.965 | 57967 | 5 |
0.970 | 73641 | 5 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online